Alvaro Herrera Pérez/LinkedIn
Jun 13, 2026, 16:21
Alvaro Herrera Pérez: Connecting Science and Care at EHA 2026
Alvaro Herrera Pérez, European MSL Lead at Agios Pharmaceuticals, shared a post on LinkedIn:
”Attending EHA 2026 at Stockholm.
Different country, same mission: collaborating with colleagues across Europe and the United States (Clinical Development and Medical Affairs) united by a common purpose: Improving outcomes for patients.
Scientific exchange, innovation, and teamwork continue to drive us forward, always with the patient at the center of everything we do.”
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome